During the past decade, Yuebei People's Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yuebei People's Hospital" #1 sponsor was "Sun Yat-sen University" with 3 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored, "Guangdong Raynovent Biotech Co., Ltd" with 1 trials sponsored, "Ming-He Huang" with 1 trials sponsored and "Shanghai Junshi Bioscience Co., Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yuebei People's Hospital" #1 collaborator was "Affiliated Cancer Hospital & Institute of Guangzhou Medical University" with 3 trials as a collaborator, "Wuzhou Red Cross Hospital" with 3 trials as a collaborator, "Yuebei People's Hospital" with 3 trials as a collaborator, "Zhongshan People's Hospital, Guangdong, China" with 3 trials as a collaborator and "Fifth Affiliated Hospital, Sun Yat-Sen University" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Yuebei People's Hospital" are "Chemotherapy" (3 trials), "Radiotherapy" (3 trials), "Nasopharyngeal Carcinoma" (2 trials), "Advanced Hepatocellular Carcinoma (HCC)" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Yuebei People's Hospital" in a lesser frequency.

Most popular intervention types in "Yuebei People's Hospital" are "Drug" (6 trials), "Combination Product" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anlotinib" (1 trials), "Anlotinib(blank)" (1 trials), "Camrelizumab plus chemo-radiotherapy" (1 trials), "Chemo-radiotherapy alone" (1 trials) and "Concurrent chemo-radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yuebei People's Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Yuebei People's Hospital". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Yuebei People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yuebei People's Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".